You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

PYRIDOSTIGMINE BROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Pyridostigmine Bromide, and when can generic versions of Pyridostigmine Bromide launch?

Pyridostigmine Bromide is a drug marketed by Amneal, Milla Pharms, MSN, Novitium Pharma, Rising, Alvogen, Impax Labs Inc, Ani Pharms, Eywa, Impax Labs, Solvay, Us Army, and Zydus Pharms. and is included in fifteen NDAs.

The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pyridostigmine Bromide

A generic version of PYRIDOSTIGMINE BROMIDE was approved as pyridostigmine bromide by IMPAX LABS on April 24th, 2003.

  Try a Trial

Summary for PYRIDOSTIGMINE BROMIDE
Drug patent expirations by year for PYRIDOSTIGMINE BROMIDE
Recent Clinical Trials for PYRIDOSTIGMINE BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Vermont Medical CenterPhase 2
Stefan Holubar MD MS FACS, FASCRSPhase 2/Phase 3
Michael Debakey Veterans Affairs Medical CenterEarly Phase 1

See all PYRIDOSTIGMINE BROMIDE clinical trials

Pharmacology for PYRIDOSTIGMINE BROMIDE
Medical Subject Heading (MeSH) Categories for PYRIDOSTIGMINE BROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for PYRIDOSTIGMINE BROMIDE

US Patents and Regulatory Information for PYRIDOSTIGMINE BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal PYRIDOSTIGMINE BROMIDE pyridostigmine bromide SYRUP;ORAL 212702-001 Jan 10, 2020 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 205650-001 Jun 22, 2015 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Impax Labs Inc PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 203184-001 Sep 15, 2015 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novitium Pharma PYRIDOSTIGMINE BROMIDE pyridostigmine bromide SYRUP;ORAL 211694-001 Mar 8, 2019 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Eywa PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 211181-001 Jul 20, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rising PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 205464-001 Aug 15, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.